Colin P. N. Dinney MDProfessor, Division of Surgery; Chairman, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Colin P. N. Dinney is the Chairman of the Department of Urology and a Professor in the Division of Surgery at The University of Texas M. D. Anderson Cancer Center. He is the PI of the M. D. Anderson Genitourinary SPORE in Bladder Cancer Research, which was awarded in September of 2001 and underwent a successful competitive renewal in 2006. In addition to administrating this program, he is actively involved in SPORE-related translational research. His laboratory has been very active in the development of novel therapeutic strategies for bladder cancer, including a major effort on the development of personalized growth-factor-directed and gene therapy. Through his collaborations at UT M. D. Anderson, the NCI, and with industry, Dr. Dinney continues to substantially expand our efforts to develop novel therapies for both early and advanced bladder cancer.
Recent Contributions to PracticeUpdate:
- Selecting the Appropriate Patient for Timely Cystectomy for Non–Muscle Invasive Bladder Cancer
- The Effect of Sex on Disease Stage and Survival After Radical Cystectomy
- Androgen Suppression Therapy Is Associated With Lower Recurrence of Non–Muscle Invasive Bladder Cancer
- Preoperative Incidence of DVT in Patients Undergoing Radical Cystectomy for Bladder Cancer
- Long-Term Renal Function Outcomes After Radical Cystectomy